153 related articles for article (PubMed ID: 36594172)
1. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019.
Ahrens K; Sharbaugh M; Jarlenski MP; Tang L; Allen L; Austin AE; Barnes AJ; Burns ME; Clark S; Zivin K; Mack A; Liu G; Mohamoud S; McDuffie MJ; Hammerslag L; Gordon AJ; Donohue JM;
Clin Infect Dis; 2023 May; 76(10):1793-1801. PubMed ID: 36594172
[TBL] [Abstract][Full Text] [Related]
2. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
; Donohue JM; Jarlenski MP; Kim JY; Tang L; Ahrens K; Allen L; Austin A; Barnes AJ; Burns M; Chang CH; Clark S; Cole E; Crane D; Cunningham P; Idala D; Junker S; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Pauly N; Sheets L; Talbert J; Zivin K; Gordon AJ; Kennedy S
JAMA; 2021 Jul; 326(2):154-164. PubMed ID: 34255008
[TBL] [Abstract][Full Text] [Related]
3. Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs.
Austin AE; Tang L; Kim JY; Allen L; Barnes AJ; Chang CH; Clark S; Cole ES; Durrance CP; Donohue JM; Gordon AJ; Huskamp HA; McDuffie MJ; Mehrotra A; Mohamoud S; Talbert J; Ahrens KA; Applegate M; Hammerslag LR; Lanier P; Tossone K; Zivin K; Burns ME
JAMA Health Forum; 2023 Jun; 4(6):e231422. PubMed ID: 37327009
[TBL] [Abstract][Full Text] [Related]
4. Estimates of Prenatal HIV, Hepatitis B Virus, and Hepatitis C Virus Testing Among Pregnant People Enrolled in Wisconsin Medicaid, 2011-2015.
Watts T; Stockman L; Martin J; Guilfoyle SM; Vergeront JM; Zahner S
Matern Child Health J; 2020 Feb; 24(2):177-185. PubMed ID: 31834607
[TBL] [Abstract][Full Text] [Related]
5. Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states.
Hammerslag L; Talbert J; Donohue JM; Sharbaugh M; Ahrens K; Allen L; Austin AE; Gordon AJ; Jarlenski M; Kim JY; Mohamoud S; Tang L; Burns M;
Drug Alcohol Depend; 2023 Sep; 250():110875. PubMed ID: 37413960
[TBL] [Abstract][Full Text] [Related]
6. Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states.
; Cole ES; Allen L; Austin A; Barnes A; Chang CH; Clark S; Crane D; Cunningham P; Fry CE; Gordon AJ; Hammerslag L; Idala D; Kennedy S; Kim JY; Krishnan S; Lanier P; Mahakalanda S; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Tang L; Zivin K; Donohue JM
Drug Alcohol Depend; 2022 Dec; 241():109670. PubMed ID: 36332591
[TBL] [Abstract][Full Text] [Related]
7. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans.
Noska AJ; Belperio PS; Loomis TP; O'Toole TP; Backus LI
Clin Infect Dis; 2017 Jul; 65(2):252-258. PubMed ID: 28379316
[TBL] [Abstract][Full Text] [Related]
9. Medications For Opioid Use Disorder Increased Among Louisiana Medicaid Enrollees During Policy Reforms, 2018-21.
Sugarman OK; Li W; Saloner B
Health Aff (Millwood); 2024 Jan; 43(1):46-54. PubMed ID: 38190602
[TBL] [Abstract][Full Text] [Related]
10. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
11. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
[TBL] [Abstract][Full Text] [Related]
12. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis.
Wu S; Wang J; Guo Q; Lan H; Sun Y; Ren M; Liu Y; Wang P; Wang L; Su R; Zhang J; Chen Y; Li G
Clin Microbiol Infect; 2023 Aug; 29(8):1000-1007. PubMed ID: 36921717
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS).
Steele WR; Dodd RY; Notari EP; Xu M; Nelson D; Kessler DA; Reik R; Williams AE; Custer B; Stramer SL;
Transfusion; 2020 Oct; 60(10):2327-2339. PubMed ID: 32869326
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
[No Abstract] [Full Text] [Related]
16. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
Taylor EA; Cantor JH; Bradford AC; Simon K; Stein BD
JAMA Netw Open; 2023 May; 6(5):e2314328. PubMed ID: 37204793
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
[TBL] [Abstract][Full Text] [Related]
19. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
[TBL] [Abstract][Full Text] [Related]
20. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]